04/09/2024
7:46 AM | Acasti Pharma (Subject)
HIRSCHMAN ORIN (Filed by)
| Form SC 13G | |
04/01/2024
7:00 AM | Acasti Pharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/13/2024
6:03 PM | Acasti Pharma (Subject)
BANK OF AMERICA CORP /DE/ (Filed by)
| Form SC 13G | |
02/12/2024
7:00 AM | Acasti Pharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/12/2024
6:30 AM | Acasti Pharma (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
01/08/2024
7:00 AM | Acasti Pharma (Issuer)
DelAversano Robert J (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
01/08/2024
6:30 AM | Acasti Pharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
|
12/15/2023
6:30 AM | Acasti Pharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/13/2023
7:10 AM | Acasti Pharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/13/2023
6:30 AM | Acasti Pharma (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
10/23/2023
3:30 PM | Acasti Pharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/20/2023
11:21 AM | Acasti Pharma (Issuer)
DAVIS A BRIAN (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
10/20/2023
11:22 AM | Acasti Pharma (Issuer)
NEUGEBOREN EDWARD (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
10/20/2023
11:23 AM | Acasti Pharma (Issuer)
Kottayil George (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
10/16/2023
11:15 PM | Acasti Pharma (Filer)
| Form EFFECT | |
10/16/2023
3:31 PM | Acasti Pharma (Filer)
| Form 424B3 | |
10/11/2023
3:30 PM | Acasti Pharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/10/2023
6:40 AM | Acasti Pharma (Filer)
| Form D
Notice of Exempt Offering of Securities | |
10/06/2023
3:30 PM | Acasti Pharma (Filer)
| Form S-3
Registration statement under Securities Act of 1933 | |
09/27/2023
6:46 PM | Acasti Pharma (Issuer)
Kavuru Vimal (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/26/2023
7:10 AM | Acasti Pharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/25/2023
4:01 PM | Acasti Pharma (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
08/25/2023
3:15 PM | Acasti Pharma (Filer)
| Form DEF 14A | |
08/25/2023
3:21 PM | Acasti Pharma (Filer)
| Form DEFA14A | |
08/11/2023
6:31 AM | Acasti Pharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/11/2023
6:15 AM | Acasti Pharma (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
07/24/2023
4:30 PM | Acasti Pharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/18/2023
3:32 PM | Acasti Pharma (Issuer)
D'Andrea Carrie (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/18/2023
3:34 PM | Acasti Pharma (Issuer)
Macdonald R. Loch (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/18/2023
3:36 PM | Acasti Pharma (Issuer)
Olds Donald (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/18/2023
3:36 PM | Acasti Pharma (Issuer)
Kavuru Vimal (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/18/2023
3:37 PM | Acasti Pharma (Issuer)
Derby Michael (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/18/2023
3:26 PM | Acasti Pharma (Issuer)
Kohli Prashant (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/18/2023
3:28 PM | Acasti Pharma (Issuer)
Kumar Amresh (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/07/2023
7:30 AM | Acasti Pharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/23/2023
6:31 AM | Acasti Pharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/23/2023
6:01 AM | Acasti Pharma (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
05/26/2023
2:06 PM | Acasti Pharma (Issuer)
Macdonald R. Loch (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
